UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chronic Virus Infection Enforces Demethylation of the Locus that Encodes PD-1 in Antigen-Specific CD8 + T Cells

Immunity (Cambridge, Mass.), 2011-09, Vol.35 (3), p.400-412

2011

Volltextzugriff (PDF)

Selective reactivation of STING signaling to target Merkel cell carcinoma

Proceedings of the National Academy of Sciences - PNAS, 2020-06, Vol.117 (24), p.13730-13739

2020

Volltextzugriff (PDF)

Strength of PD-1 signaling differentially affects T-cell effector functions

Proceedings of the National Academy of Sciences - PNAS, 2013-07, Vol.110 (27), p.E2480-E2489

2013

Volltextzugriff (PDF)

Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor

PLoS pathogens, 2017-10, Vol.13 (10), p.e1006613-e1006613

2017

Volltextzugriff (PDF)

PD-1 signaling in primary T cells

Immunological reviews, 2009-05, Vol.229 (1), p.114-125

Riley, James L

2009

Volltextzugriff (PDF)

Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein

PLoS pathogens, 2010-09, Vol.6 (9), p.e1001098-e1001098

2010

Volltextzugriff (PDF)

Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains

Proceedings of the National Academy of Sciences - PNAS, 2009-03, Vol.106 (9), p.3360-3365

2009

Volltextzugriff (PDF)

Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells

PLoS pathogens, 2023-12, Vol.19 (12), p.e1011853-e1011853

2023

Volltextzugriff (PDF)

CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV

Frontiers in immunology, 2019-09, Vol.10, p.2310-2310

2019

Volltextzugriff (PDF)

CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms

Molecular and Cellular Biology, 2005-11, Vol.25 (21), p.9543-9553

2005

Volltextzugriff (PDF)

The battle over mTOR: an emerging theatre in host-pathogen immunity

PLoS pathogens, 2012-09, Vol.8 (9), p.e1002894

2012

Volltextzugriff (PDF)

Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells

PloS one, 2011-01, Vol.6 (1), p.e15868

2011

Volltextzugriff (PDF)

Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus

PLoS pathogens, 2016-11, Vol.12 (11), p.e1005983

2016

Volltextzugriff (PDF)

FOXP3 Interactions with Histone Acetyltransferase and Class II Histone Deacetylases Are Required for Repression

Proceedings of the National Academy of Sciences - PNAS, 2007-03, Vol.104 (11), p.4571-4576

2007

Volltextzugriff (PDF)

Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases

PLoS pathogens, 2011-04, Vol.7 (4), p.e1002020-e1002020

2011

Volltextzugriff (PDF)

Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs

Clinical immunology (Orlando, Fla.), 2010-09, Vol.136 (3), p.348-363

2010

Volltextzugriff (PDF)

Differential Reliance on Lipid Metabolism as a Salvage Pathway Underlies Functional Differences of T Cell Subsets in Poor Nutrient Environments

Cell reports (Cambridge), 2018-04, Vol.23 (3), p.741-755

2018

Volltextzugriff (PDF)

Efficient Clinical Scale Gene Modification via Zinc Finger Nuclease–Targeted Disruption of the HIV Co-receptor CCR5

Human gene therapy, 2013-03, Vol.24 (3), p.245-258

2013

Volltextzugriff (PDF)

Genetic engineering of T cells for immunotherapy

Nature reviews. Genetics, 2021-07, Vol.22 (7), p.427-447

2021

Volltextzugriff (PDF)

Combination Checkpoint Blockade — Taking Melanoma Immunotherapy to the Next Level

The New England journal of medicine, 2013-07, Vol.369 (2), p.187-189

Riley, James L

2013

Volltextzugriff (PDF)

The CD28 Signaling Pathway Regulates Glucose Metabolism

Immunity (Cambridge, Mass.), 2002-06, Vol.16 (6), p.769-777

2002

Volltextzugriff (PDF)

CAR T cells for infection, autoimmunity and allotransplantation

Nature reviews. Immunology, 2018-10, Vol.18 (10), p.605-616

2018

Volltextzugriff (PDF)

Role of PD-1 during effector CD8 T cell differentiation

Proceedings of the National Academy of Sciences - PNAS, 2018-05, Vol.115 (18), p.4749-4754

2018

Volltextzugriff (PDF)

Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1

PLoS biology, 2010-02, Vol.8 (2), p.e1000302-e1000302

2010

Volltextzugriff (PDF)

Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes

Journal of translational medicine, 2011-08, Vol.9 (1), p.131-131, Article 131

2011

Volltextzugriff (PDF)

1 – 25 von 883

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(824)
Mit Volltextzugriff
(723)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(591)
Life Sciences & Biomedicine
(486)
Humans
(359)
Male
(165)
Female
(158)
Animals
(127)
Biological And Medical Sciences
(119)
Middle Aged
(83)
Adult
(81)
Medical Sciences
(78)
Physical Sciences
(67)
Immunology
(66)
Aged
(59)
Mice
(55)
Neurosciences & Neurology
(54)
Fundamental And Applied Biological Sciences. Psychology
(49)
General & Internal Medicine
(43)
Environmental Sciences & Ecology
(42)
Medicine, Research & Experimental
(41)
Research & Experimental Medicine
(41)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Chronic Virus Infection Enforces Demethylation of the Locus that Encodes PD-1 in Antigen-Specific CD8 + T Cells

Selective reactivation of STING signaling to target Merkel cell carcinoma

Strength of PD-1 signaling differentially affects T-cell effector functions

Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor

PD-1 signaling in primary T cells

Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein

Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains

Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells

CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV

CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms

The battle over mTOR: an emerging theatre in host-pathogen immunity

Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells

Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus

FOXP3 Interactions with Histone Acetyltransferase and Class II Histone Deacetylases Are Required for Repression

Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases

Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs

Differential Reliance on Lipid Metabolism as a Salvage Pathway Underlies Functional Differences of T Cell Subsets in Poor Nutrient Environments

Efficient Clinical Scale Gene Modification via Zinc Finger Nuclease–Targeted Disruption of the HIV Co-receptor CCR5

Genetic engineering of T cells for immunotherapy

Combination Checkpoint Blockade — Taking Melanoma Immunotherapy to the Next Level

The CD28 Signaling Pathway Regulates Glucose Metabolism

CAR T cells for infection, autoimmunity and allotransplantation

Role of PD-1 during effector CD8 T cell differentiation

Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1

Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes

Suchergebnisse filtern